Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Mima

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
European Journal of Pharmacology|October 22, 2021
Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantagesAkira Mima
Heliyon|March 10, 2022
Mitochondria-targeted drugs for diabetic kidney diseaseAkira Mima
Rheumatology International|March 4, 2017
Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitisAkira Mima
Scientific Reports|October 21, 2022
Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based studyAkira Mima
Journal of Diabetes and Its Complications|June 9, 2018
Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney diseaseAkira Mima
In Vivo (Athens, Greece)|April 27, 2023
Safety and Efficacy of Imeglimin for Type 2 Diabetes in Patients Undergoing DialysisAkira Mima
Journal of Diabetes Research|July 18, 2013
Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsAkira Mima
Advances in Therapy|June 25, 2022
A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic ApproachesAkira Mima
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 24, 2012
Hemodialysis vascular access dysfunction: molecular mechanisms and treatmentAkira Mima
In Vivo (Athens, Greece)|March 7, 2023
Enarodustat Treatment for Renal Anemia in Patients With Non-dialysis Chronic Kidney DiseaseAkira Mima
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
European Journal of Pharmacology|October 22, 2021
Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantagesAkira Mima
Heliyon|March 10, 2022
Mitochondria-targeted drugs for diabetic kidney diseaseAkira Mima
Rheumatology International|March 4, 2017
Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitisAkira Mima
Scientific Reports|October 21, 2022
Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based studyAkira Mima
Journal of Diabetes and Its Complications|June 9, 2018
Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney diseaseAkira Mima
In Vivo (Athens, Greece)|April 27, 2023
Safety and Efficacy of Imeglimin for Type 2 Diabetes in Patients Undergoing DialysisAkira Mima
Journal of Diabetes Research|July 18, 2013
Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsAkira Mima
Advances in Therapy|June 25, 2022
A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic ApproachesAkira Mima
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 24, 2012
Hemodialysis vascular access dysfunction: molecular mechanisms and treatmentAkira Mima
In Vivo (Athens, Greece)|March 7, 2023
Enarodustat Treatment for Renal Anemia in Patients With Non-dialysis Chronic Kidney DiseaseAkira Mima
Pageof 9